-
Urate and homocysteine: Changes in motor and cognitive symptoms in newly diagnosed Parkinson’s disease
-
Use of dementia rating scale-II (DRS-II) total score in PD deep brain stimulation (DBS) candidacy determination
-
Use of nicotine gum to treat acute low blood pressure in Parkinson’s disease
-
Use of the physiotherapy in the treatment of initial stages of Parkinson’s disease
-
Usefulness of total neuropathy score revised as a screening tool of peripheral neuropathy in patients with Parkinson’s disease
-
Using wavelet coherence analysis to distinguish between tremor types
-
Utility of IgGs subtypes in hemolytic anemia prevention and treatment maintenance in patients treated with continous infusion of apomorphine
-
Utility of the Mayo sleep questionnaire in predicting final autopsy diagnosis of alpha-synucleinopathy
-
Utility of the Montreal cognitive assessment for screening of mild cognitive impairment and dementia associated with Parkinson’s disease in a Colombian hospital
-
Utilization and longitudinal impact of amantadine use in Parkinson’s disease. National Parkinson Foundation (NPF) QII registry
- « Previous Page
- 1
- …
- 200
- 201
- 202
- 203
- 204
- …
- 207
- Next Page »